13
Views
1
CrossRef citations to date
0
Altmetric
Letters

The Case of Chromium(VI)

Pages 425-428 | Published online: 19 Jul 2013

References

  • http://www.dhs.ca.gov/psiddwern/chemicals/chromium6/reviewpanelreport.pdf.
  • International Agency for Research on Cancer (IARC). Chromium and Chromium Compounds. IARC Mono-graph Evaluating Carcinogenic Risks to Humans. 1990; 49: 49–214
  • Borneff J, Engelhardt K, Griem W, Kunte H, Reichert J. [Carcinogens in Water and Soil. XXII. Experiment with 3,4-lienzopyrene and Potassium Chro-mate in Mice Drink]. Arch Hyg Bakte-riol. 1968; 152: 45–53.
  • Kerger BD, Finley BL, Corbett GE, Dodge DG, Paustenbach DJ. Ingestion of chromium(VI) in drinking water by human volunteers: absorption, distribution, and excretion of single and repeated doses. J Toxicol Environ Health. 1997; 50: 67–95.
  • Kerger BD, Paustenbach DJ, Corbett GE, Finley BL. Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol Appl Pharmacol. 1996; 141: 145–58.
  • Finley BL, Kerger BD, Katona MW, Gargas ML, Corbett GC, Paustenbach DJ. Human ingestion of chromium (VI) in drinking water: pharmacoldnet-ics following repeated exposure. Toxi-col Appl Pharmacol. 1997; 142: 151–9.
  • Paustenbach DJ, Finley BL, Mowat FS, Kerger BD. Human health risk and exposure assessment of chromium (VI) in tap water. J Toxicol Environ Health A. 2003; 66: 1295–339.
  • Simonian HP, Vo L, Doma S, Fisher RS, Parkman HP. Regional postprandial differences in pH within the stomach and gastroesophageal junction. Dig Dis Sci. 2005; 50: 2276–85.
  • http://www.imshealth.com/ims/portal/front/articlec/0.2777.6599_3665_69890098.00.html.
  • Miner P Jr, Katz PO, Chem Y, Sostek M. Reanalysis of intragastric pH results based on updated correction factors for Slimline and Zinetics 24 single-use pH catheters. Am J Gastroenterol. 2006; 101: 404–5.
  • Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol. 2004; 160: 339–19.
  • http://www.dhs.ca.gov/ps/ddwem/chemicals/chromium6/reviewpanelreport.pdf.2006.
  • Hoel DG, Haseman JK, Hogan MD, Huff J, McConnell EE. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Car-cinogenesis. 1998; 9: 2045–52.
  • http://www.dhs.ca.gov/ps/ddwem/chemicals/chromium6/reviewpanelreport.pdf.2006.
  • Murthy AS, McConnell EE, Huff JE, Russfield AB, Good AE. Forestomach neoplasms in Fischer F344/N rats and B6C3F1 mice exposed to diglycidyl resorcinol ether-an epoxy resin. Food Chem Toxicol. 1990; 28: 723–9.
  • Dick EJ Jr, Kittell CL, Meyer H, et al. Mousepox outbreak in a laboratory mouse colony. Lab Anim Sci. 1996; 46: 602–11.
  • Huff JE, Eustis SL, Haseman JK. Occur-rence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies. Cancer Metastasis Rev. 1989; 8: 1–22.
  • Borneff J, Engelhardt K, Griem W, Kunte H, Reichert J. [Carcinogens in water and soil. XXII. Experiment with 3,4-benzopyrene and potassium chro-mate in mice drink]. Arch Hyg Bakte-riol. 1968; 152: 45–53.
  • http://www.ewg.org/reports/chromium/retraction.php.
  • von Saal FS, Hughes C. An extensive new literature concerning low-dose effects if bisphenol A shows the need for a new risk assessment. Environ Health Perspect. 2006;114A16-17.
  • HE Stevenson, et al, Plaintiffs, vs. E I Dupont De Nemours and Company, Dis-trict Court for the Southern District of Texas, Victoria. v-01-CV-24.
  • Popp JA, Crouch E, McConnell EE. A weight-of-evidence analysis of the cancer dose-response characteristics of 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Toxicol Sci. 2006; 89: 361–9.
  • Maxim LD, McConnell EE. A review of the toxicology and epidemiology of wollastonite. Inhal Toxicol. 2005; 17: 451–66.
  • McConnell EE, Axten C, Hesterberg TW, et al. Studies on the inhalation tox-icology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol. 1999; 11: 785–835.
  • Kamstrup 0, Ellehauge A, Chevalier J, Davis JM, McConnell EE, Thevenaz P. Chronic inhalation studies of two types of stone wool fibers in rats. Inhal Toxi-col. 2001; 13: 603–21.
  • Hesterberg TW, Miller WC, Mast R, McConnell EE, Bernstein DM, Ander-son R. Relationship between lung biop-ersistence and biological effects of man-made vitreous fibers after chronic ' inhalation in rats. Environ Health Per-spect. 1994;102 suppl 5: 133-7.
  • http://www.ewg.org/reports/chromium/retraction.php.
  • http://www.dhs.ca.gov/ps/ddwem/chemicals/chromium6/cr+6timeline.htm.
  • Sedman RM, Beaumont J, McDonald TA, Reynolds S, Krowech G, Howd Review of the evidence regarding the carcinogenicityofhexavalentchromium in drinking water. J Environ Sci Health C Environ Carcinog Ecotox-icol Rev. 2006; 24: 155–82.
  • Costa M, Klein CB. Toxicity and car-cinogenicity of chromium compounds in humans. Grit Rev Toxicol. 2006; 36: 155–63.
  • Costa M. Potential hazards of hexava-lent chromate in our drinking water. Toxicol Appl Pharmacol. 2003; 188: 1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.